Ken Griffin Evolent Health, Inc. Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$19.12 - $31.93 $195,024 - $325,686	-10,200 Reduced 12.39%	72,100 $1.38 Million
Q1 2024 May 15, 2024	BUY	$29.41 - $34.72 $1.28 Million - $1.51 Million	43,500 Added 112.11%	82,300 $2.7 Million
Q4 2023 Feb 14, 2024	BUY	$23.63 - $33.52 $354,450 - $502,800	15,000 Added 63.03%	38,800 $1.28 Million
Q3 2023 Nov 14, 2023	BUY	$25.0 - $31.4 $277,500 - $348,540	11,100 Added 87.4%	23,800 $648,000
Q2 2023 Aug 14, 2023	SELL	$28.05 - $36.44 $260,865 - $338,892	-9,300 Reduced 42.27%	12,700 $384,000
Q1 2023 May 15, 2023	BUY	$26.35 - $35.8 $18,445 - $25,059	700 Added 3.29%	22,000 $713,000
Q4 2022 Feb 14, 2023	SELL	$22.21 - $37.41 $537,482 - $905,321	-24,200 Reduced 53.19%	21,300 $598,000
Q3 2022 Nov 14, 2022	BUY	$29.37 - $39.74 $854,667 - $1.16 Million	29,100 Added 177.44%	45,500 $1.64 Million

267

124M

519K

1.2M

Ticker EVH
Exchange NYSE
Sector Healthcare
Industry Health Information Services
Shares Outstandng 97,063,696
Market Cap $2.84B
Description
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical pl...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.